Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Current and Novel
Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to develop their own immune therapy drugs. 
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Disrupting the Industry through Implementation of Pharma 4.0 Technologies

Pharmaceutical manufacturers are facing unprecedented challenges from supply chain disruptions, significant demand fluctuations, reliability.
Watch Now

New Drug Pricing Strategies for a Changing Global Market

questexweb

Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
Watch Now

Leveraging Success of COVID-19 Vaccine Development

The pandemic was a unique time in our industry where there was a perfect storm of need, money, collaboration, and trial patients all available in abundance.  There was an atmosphere of all hands, and resources, on deck in the race to a COVID-19 vaccine.
Watch Now

New Tools to Advance CNS Drug Delivery

Business-review-webinars

This webinar will focus on the advantages of nasal powder formulations and on a non-human primate (NHP) model to quantify nose-to-brain delivery of a model compound, sumatriptan. The webinar will also compare pharmacokinetic advantages of nasal powders versus aqueous formulations, as well as in vitro results of nasal powder delivery.
Watch Now

Spotlight

resources